Rephonic
Artwork for Drugwatch Investigates

Drugwatch Investigates

Drugwatch.com
Ozempic
Glp-1 Drugs
Wegovy
Diabetes
Glp-1 Medications
FDA
Obesity
Weight Loss
Lyraglutide
Vioxx
Texas Two-Step
Glyphosate
Lip Products
Side Effects
Heart Disease
Diabetes Treatment
Health Risks
Chronic Illness
Metabolic Health
Compounding Pharmacies

Drugwatch Investigates goes beyond the headlines to examine the drugs, devices and decisions that affect millions of Americans. Powered by the investigative journalists and consumer advocates of Drugwatch.com, each series combines expert voices with in-depth research to deliver the stories behind the science and the truth behind the treatments.

PublishesMonthlyEpisodes18Foundeda year ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for Drugwatch Investigates

Latest Episodes

If you or a loved one developed vision loss while taking Ozempic or Wegovy, you may be eligible for a lawsuit. Learn more and get a free case review: www.drugwatch.com/drugs/ozempic/vision-loss/

───────────────────────────────────────

Tens... more

YouTube

Meta, the company behind Instagram and Facebook, has spent years in courtrooms arguing that its platforms are safe and not addictive for kids. But local governments and individuals have taken the social media giant to court, claiming that its digital... more

YouTube

Every single day, you probably apply lip products without a second thought. But what if the ingredients in your favorite lip gloss, lip balm or lip mask were never tested for what happens when they go into your body? And what if those same products c... more

YouTube

What did Meta and YouTube know about the harm they were causing to children — and when did they know it? The evidence just went before a jury for the first time, and the verdict is in.

In this episode, attorney and consumer safety advocate Whitney D... more

YouTube

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

The Daily
The DailyThe New York Times

Recent Guests

Ellen Relkin
Partner and chair of the Defective Drugs and Devices Department at Weitz and Luxenberg
Weitz and Luxenberg
Episode: Ozempic on Trial: The Vision Loss Risk Nobody Is Warning You About
Christian Simmons
Reporter with Drugwatch and author of the investigation Big Tech on Trial
Drugwatch
Episode: Big Tech on Trial: Inside Meta's Landmark Settlement and What It Means for Your Kids
Laura DiGirolamo
Founder of YOM Beauty and The Lip Service Alliance
YOM Beauty / Lip Service Alliance
Episode: Health on Trial: Inside the Biggest Blind Spot in Beauty History
Nicki Petrossi
Former social media marketing executive; host of Scrolling 2 Death
Independent advocate; author
Episode: Health on Trial: Inside the Landmark Addiction Case Against Meta and YouTube
Kelly Ryerson
Glyphosate Girl, advocate and blogger
Independent activist
Episode: Health on Trial: The Dangers of Roundup and the Fight for Our Legal Rights
Shannon Brownlee
Investigative journalist on the episode team
Drugwatch
Episode: Big Pharma Behind the Scenes Ep. 6: Fixing the System — Can Drug Safety Be Rebuilt?
Jeannie Lenzer
Consumer safety advocate and journalist
Drugwatch
Episode: Big Pharma Behind the Scenes Ep. 6: Fixing the System — Can Drug Safety Be Rebuilt?
Lewis Clark
Whistleblower advocate with decades of inside experience
Independent
Episode: Big Pharma Behind the Scenes Ep. 6: Fixing the System — Can Drug Safety Be Rebuilt?
Nora Freeman-Ingstrom
Stanford Law Professor
Stanford Law School
Episode: Big Pharma Behind the Scenes Ep. 6: Fixing the System — Can Drug Safety Be Rebuilt?

Hosts

Whitney Di Bona
Host of health and consumer-safety focused investigations; attorney and consumer safety advocate.
Terry Turner
Host of investigative program strands and Drugwatch Investigates series; senior writer and show facilitator.

Reviews

5.0 out of 5 stars from 16 ratings
  • A Podcast for the Ages

    An exceptional listen! I highly recommend you listen to this as there are a lot of unknowns surrounding Ozempic. The hosts break it down in a clear and understandable way. Looking forward to more!

    Apple Podcasts
    5
    Mansa_Musa99
    United Statesa year ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Critical: incisive digging into drug safety and corporate practices.
Impactful guest selection that provides diverse expert perspectives.
Clear, accessible discussion of complex policy issues for a general audience.

Top Medicine Podcasts

Talking Points

Recent interactions between the hosts and their guests.

Ozempic on Trial: The Vision Loss Risk Nobody Is Warning You About
Q: Who would qualify for these lawsuits and what information is needed?
Qualified individuals typically have a diagnosed NAION event, were on Wegovy or Ozempic at the time or shortly before the event, and have no other overriding cause for the vision loss. The process requires medical records, documentation of treatment timelines, and evidence of exposure to the drug to establish a causal link or contributory role in the condition.
Ozempic on Trial: The Vision Loss Risk Nobody Is Warning You About
Q: What changes would you like to see in labeling or medical practice to mitigate risk?
We advocate for explicit warning language on labels, routine baseline eye examinations for patients before starting GLP-1 therapies, and clear guidance on monitoring and stopping the drug if NAION signs appear. This aligns medical practice with regional labeling standards and improves informed decision-making for patients.
Ozempic on Trial: The Vision Loss Risk Nobody Is Warning You About
Q: What is the status of litigation and where are cases being filed?
Most primary litigations are against the brand-name drugs Novo Nordisk and Lilly, with many cases filed in New Jersey state court and a federal MDL in Philadelphia. The strategy emphasizes state court trials for faster resolutions and bellwether cases, while the federal MDL involves more complex preemption defenses and discovery-heavy processes.
Ozempic on Trial: The Vision Loss Risk Nobody Is Warning You About
Q: Could you summarize why the NAION risk matters for patients considering Ozempic or Wegovy?
The NAION risk matters because it can cause sudden, irreversible vision loss with little to no warning. While rare, the consequences are severe and potentially life-altering, especially for people who rely on vision for work or daily activities. Given the large number of people on these drugs, even a small risk translates into many affected individuals, so proper screening and warning are essential.
Big Pharma Behind the Scenes Ep. 5: Record Settlements — Vioxx and Major MDLs Move the Needle
Q: So Whitney, when you look at these record MDLs, what stands out to you from an attorney's perspective?
MDLs concentrate risk and information, enabling coordinated discovery, bellwether trials, and one judge to see the full picture, which often makes billion-dollar settlements possible while also creating a public record of internal documents and expert reports that can influence regulators and future cases.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Drugwatch Investigates

What is Drugwatch Investigates about and what kind of topics does it cover?

This program spotlights deep-dive investigations into drugs, devices, and regulatory decisions that affect public health and safety. Recent episodes cover Big Tech's influence on youth and mental health, regulatory gaps in beauty and cosmetics, MDL-driven settlements in pharma, and high-profile litigation against Roundup and other treatments. The show often features investigative journalism, legal and policy analysis, and firsthand perspectives from industry insiders, whistleblowers, and researchers. A standout trait is its willingness to connect complex science with practical implications for families, policymakers, and practitioners, while challenging industry narratives and seeking accountability.

Where can I find podcast stats for Drugwatch Investigates?

Rephonic provides a wide range of podcast stats for Drugwatch Investigates. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Drugwatch Investigates and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Drugwatch Investigates get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for Drugwatch Investigates, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Drugwatch Investigates?

Rephonic provides comprehensive predictive audience data for Drugwatch Investigates, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Drugwatch Investigates have?

To see how many followers or subscribers Drugwatch Investigates has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Drugwatch Investigates?

These podcasts share a similar audience with Drugwatch Investigates:

1. The Daily

How many episodes of Drugwatch Investigates are there?

Drugwatch Investigates launched a year ago and published 18 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Drugwatch Investigates?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Drugwatch Investigates?

Rephonic pulls ratings and reviews for Drugwatch Investigates from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Drugwatch Investigates?

Rephonic provides full transcripts for episodes of Drugwatch Investigates. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Drugwatch Investigates?

Recent guests on Drugwatch Investigates include:

1. Ellen Relkin
2. Christian Simmons
3. Laura DiGirolamo
4. Nicki Petrossi
5. Kelly Ryerson
6. Shannon Brownlee
7. Jeannie Lenzer
8. Lewis Clark

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days